688029 南微醫學
按盤價 
79.060 +6.410 (+8.823%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.296 | 14.336 | 14.876 | 14.215 | 10.719 |
| 總資產報酬率 ROA (%) | 5.566 | 11.136 | 12.063 | 11.728 | 8.786 |
| 投入資產回報率 ROIC (%) | 6.675 | 13.357 | 14.271 | 13.704 | 10.467 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.853 | 64.094 | 67.653 | 64.504 | 60.950 |
| 營業利潤率 (%) | 21.858 | 21.725 | 23.931 | 23.001 | 18.391 |
| 息稅前利潤/營業總收入 (%) | 25.228 | 19.634 | 22.140 | 20.198 | 15.514 |
| 淨利潤/營業總收入 (%) | 17.852 | 18.298 | 20.617 | 20.514 | 16.809 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.436 | 101.698 | 104.751 | 98.627 | 93.493 |
| 價值變動淨收益/利潤總額(%) | 2.272 | 2.586 | 3.036 | 4.928 | 11.752 |
| 營業外收支淨額/利潤總額(%) | 0.037 | -0.077 | 0.055 | 1.813 | 1.009 | 償債能力分析 |
| 流動比率 (X) | 3.566 | 3.628 | 4.118 | 5.067 | 5.343 |
| 速動比率 (X) | 2.892 | 3.009 | 3.452 | 4.264 | 4.327 |
| 資產負債率 (%) | 19.107 | 20.528 | 18.417 | 16.448 | 15.910 |
| 帶息債務/全部投入資本 (%) | 5.440 | 6.737 | 2.141 | 2.199 | 1.131 |
| 股東權益/帶息債務 (%) | 1,696.666 | 1,346.021 | 4,483.795 | 4,358.737 | 8,580.466 |
| 股東權益/負債合計 (%) | 402.933 | 368.257 | 434.663 | 499.910 | 520.536 |
| 利息保障倍數 (X) | 7.503 | -9.466 | -12.267 | -6.258 | -5.064 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 57.073 | 54.876 | 55.137 | 51.670 | 57.921 |
| 存貨周轉天數 (天) | 185.496 | 182.287 | 213.687 | 228.962 | 223.846 |
| 備註： | 即時報價更新時間為 15/09/2026 16:27 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
